New bladder cancer drug could spare patients from losing their bladder
Disease control
Not yet recruiting
This phase 3 study tests a new drug called NDV-01 for people with non-muscle invasive bladder cancer. The drug is given directly into the bladder to help prevent the cancer from coming back or getting worse. The study includes two groups: one with intermediate-risk cancer compari…
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated May 04, 2026 16:30 UTC